Background Recent studies have focused on whether different hepatitis C virus (HCV) genotypes are associated with different profiles of pathogenicity, infectivity, and response to antiviral therapy. We needed to develop a convenient screening test for HCV genotypes 1 and 2.
Introduction
The genotype of hepatitis C virus (HCV) is associated with di¡erent pro¢les of pathogenicity, infectivity and response to antiviral therapy. 1, 2 A large number of methods for the determination of the HCV genotypes have been developed. However, these methods are laborious and expensive. In the present study, we developed a simple and convenient method for the determination of HCV genotypes 1 and 2 based on melting curve analysis.
Materials and methods
Serum samples were obtained from 55 patients with known chronic HCV infection con¢rmed to be antibody-positive by immunoblot assay. Serum samples derived from 20 healthy blood donors served as negative controls. Viral RNA was extracted from serum samples using the Mag Extractor 1 MFX 2000 with a viral RNA kit (Toyobo Co., Ltd, Tokyo, Japan), according to the manufacturer's instructions. The reverse transcriptase-polymerase chain reaction (PCR) was performed as previously described using primers from the core region. 3 The forward primer was 5'-CGCGCGACTAGGAAGACTTC -3' (no. 256); the reverse primer was 5'-ATGTACCCCATGAGGTCGGC-3' (no. 186). The primer pair was designed to amplify a 272-base pair fragment within the core region of each HCV genotype. cDNA synthesis was performed with 10 mL of extracted RNA, 0.4 mmol/L of primer no. 186, 1mmol/ L of each dNTP, 5 U of avian myeloblastosis virus reverse transcriptase XL and 2 mL of RNA PCR bu¡er (TaKaRa Biomedicals, Tokyo, Japan) in a ¢nal volume of 20 mL. The reaction was performed in a GeneAmp PCR system 9600 thermocycler (Applied Biosystems, Wellesley MA, USA) for 10 min at 308C, 30 min at 428C and 5 min at 998C. The PCR mixture contained cDNA prepared as above, 2 mL of Light-Cycler-FastStart DNA Master SYBR Green I (Roche Molecular Biochemicals, Mannheim, Germany), 0.5 mmol/L of each primer (nos 256 and 186), and 14 mL of H 2 O in a ¢nal volume of 20 mL. The optimal concentration of magnesium chloride was 2 mmol/ L. PCR was performed in 33 cycles of 10 s at 988C, 4 s at 588C, 15 s at 728C, with £uorescence detection at 728C after each cycle using the LightCycler (Roche) with closed glass capillaries. After the ¢nal cycle, a meltingpoint analysis was performed within the range 72-988C, where SYBR Green I binds to double-stranded DNA molecules. A characteristic melting pro¢le for each genotype was obtained by monitoring the £uorescence as the temperature increased beyond the melting point of the PCR product. Serum samples were also subjected to genotype analysis by the method previously described. 3
Results and discussion
Of the 55 samples, 32 were found to have HCV subtype 1b, 15 samples had subtype 2a and 8 had subtype 2b. Subtype 1a was not detected in these patients. The frequency of genotype 1a is known to be only 0.8% in Japanese patients; Japanese HCV carriers are exclusively infected with HCV subtype 1b, 2a or 2b. 4 The results of the melting curve analysis for subtype 1b, 2a and 2b samples and an HCV RNA-negative sample are shown in Fig. 1 . The mean (standard deviation) melting temperatures (T m ) for subtypes 1b, 2a and 2b were 93.148C (0.5128C), 91.088C (0.498C) and 91.708C (0.278C), respectively. We successfully di¡erentiated genotypes1 and 2 by the range of T m . The concordance decreased to 98.18% at the subtype level, because a sample with subtype 2a had a T m overlapping that for subtype 2b. This discrepancy hardly diminishe s the usefulness of this method, because no di¡erence has been reported in the sensitivity to interferon therapy between the two subtypes. 1 Although subtype 1a was not included in this study, this subtype might show a similar T m range as subtype 1b, because the G+C content of ampli¢ed regions was 66.18% for both subtype 1a and subtype 1b (GenBank accession numbers AF011753 and AF333324). Serially diluted samples with high copies of HCV RNA of each subtype (1b, 2a and 2b) in virus-free serum were subjected to the assay. The detection limit was determined to be 1kIU/mL for each subtype. None of 20 samples from healthy blood donors showed a positive result.
Although methods of HCV genotyping based on melting curve analysis have been reported previously, 5, 6 they require several sets of £uorescence resonance energy transfer probes for di¡erent HCV genotypes, whereas our method can be done with only one common primer pair and SYBR Green I.
In conclusion, the described method allows a rapid and simple di¡erentiation between HCV genotypes 1 and 2. 
